GPCR
Structure Therapeutics Inc.
35.10$
-2.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +1,229.5% | +134.0% | +52.3% | +173.7% | +50.1% | |
| – | – | – | – | – | – | |
| – | +235,349.7% | +24.3% | +93.7% | +55.2% | +107.0% | |
| – | +242,277.2% | +90.7% | +99.6% | +51.2% | +24.6% | |
| – | +236,892.3% | +39.4% | +95.5% | +54.0% | +79.3% | |
| – | – | – | – | – | – | |
| – | +2,443,120.0% | +1,155.7% | +772.9% | – | – | |
| – | – | – | – | – | – | |
| – | +167,291.3% | -92.6% | +1,288.2% | +31.4% | +66.1% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.